dc.contributor.author |
Grynevych, Oleksandr
|
|
dc.contributor.author |
Borshov, Sergiy
|
|
dc.contributor.author |
Matyash, Victor
|
|
dc.contributor.author |
Momotiuk, Liudmyla
|
|
dc.contributor.author |
Motuzka, Olena
|
|
dc.contributor.author |
Yashchenko, Lyudmila
|
|
dc.date.accessioned |
2022-03-25T17:52:30Z |
|
dc.date.available |
2022-03-25T17:52:30Z |
|
dc.date.issued |
2021 |
|
dc.identifier.citation |
Proteflazid effectiveness for prevention and treatment of acute viral respiratory infections in the conditions of COVID-19 / Grynevych Oleksandr, Borshov Sergiy, Matyash Victor, Momotiuk Liudmyla, Motuzka Olena, Yashchenko Lyudmila // Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. - 2021. - Vol. 49 (292). - P. 255-265. |
en_US |
dc.identifier.uri |
http://ekmair.ukma.edu.ua/handle/123456789/22840 |
|
dc.description.abstract |
The aim of the study was to provide a statistical assessment of the effectiveness
of the drug Proteflazid, drops in terms of COVID-19 pandemic. |
en_US |
dc.description.abstract |
Celem pracy była prezentacja oceny statystycznej zastosowania środka leczniczego Proteflazid w kroplach w warunkach pandemii COVID -19. |
pl_PL |
dc.language.iso |
en |
uk_UA |
dc.subject |
Proteflazid |
en_US |
dc.subject |
SARS-CoV-2 |
en_US |
dc.subject |
"off–label use" |
en_US |
dc.subject |
COVID-19 prevention and treatment |
en_US |
dc.subject |
article |
en_US |
dc.subject |
Proteflazid |
pl_PL |
dc.subject |
SARS-CoV-2 |
pl_PL |
dc.subject |
"off–label use" |
pl_PL |
dc.subject |
profilaktyka i leczenie ŃOVID-19 |
pl_PL |
dc.title |
Proteflazid effectiveness for prevention and treatment of acute viral respiratory infections in the conditions of COVID-19 |
en_US |
dc.title.alternative |
Skuteczność Proteflaziduw profilaktyce i leczeniu wirusowych ostrych zakażeń oddechowych w czasie COVID-19 |
pl_PL |
dc.type |
Article |
en_US |
dc.status |
first published |
uk_UA |
dc.relation.source |
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego |
pl_PL |